Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Optogenetics Market Thrives Amid Rising Neurological DisordersThe optogenetics market, driven by advancements in neuroscience and rising neurological disorders, is projected to grow from USD 580.7 million in 2023 to USD 772.7 million by 2030.
By: P&S Intelligence The rise in neurological disorders, due to infections, genetic factors, brain and spinal cord injuries, and congenital anomalies, is also fueling market growth. The global incidence of neurological conditions has increased over time. The growing prevalence of these chronic illnesses, along with the pressures of modern life and financial stress, is anticipated to drive demand for the diagnosis and treatment of psychiatric disorders, where optogenetics is used to monitor behavior. Currently, around 20% of the world's adolescents and children suffer from psychiatric issues, a number that is steadily rising, with suicide being the second-leading cause of death among 15–29-year- Browse detailed report analysis on Optogenetics Market Share, Development and Forecast Report, 2030 (https://www.psmarketresearch.com/ In the light equipment market, the laser category led with approximately 60% of the revenue in 2023, a trend expected to continue throughout the decade. Laser technology is widely used in biotechnology and neuroscience to deliver precise optical laser radiation to specific areas of interest. Technological advancements have led to the creation of compact, portable laser sources designed for use in clinical and diagnostic laboratories, offering user-friendly designs, long operational lifespans exceeding 10,000 hours, durability, and consistent performance. In 2023, the channelrhodopsin category was the leading actuator segment, a trend projected to continue. Channelrhodopsins enable rapid neuron depolarization when exposed to light by directly stimulating ion channels. Blue light excites channelrhodopsins, allowing non-specific cation entry into cells. This first widely recognized optogenetic tool is a cation channel activated by blue light, showing high conductance at physiological pH and integrating well into the membrane. North America held the largest market share in 2023, with about 55% of the total value, a dominance expected to persist throughout the forecast period. The U.S. contributes significantly to this regional market due to the increasing prevalence of severe behavioral conditions, such as Parkinson's disease and schizophrenia. End
|
|